These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29164380)

  • 21. Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction.
    Chung SJ; Yoo HS; Moon H; Oh JS; Kim JS; Park YH; Hong JY; Ye BS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):169-174. PubMed ID: 28912301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of rs591323 on serotonin transporter availability in healthy male subjects.
    Pak K; Nam HY; Shin S; Kim K; Lee MJ; Kim EJ; Lee JM; Kim SJ; Kim IJ
    Ann Nucl Med; 2018 Aug; 32(7):431-436. PubMed ID: 29774458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Baldwin RM; Zoghbi S; Zea-Ponce Y; Charney DS; van Dyck CH; Hoffer PB; Innis RB
    J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease.
    Rektorova I; Srovnalova H; Kubikova R; Prasek J
    Mov Disord; 2008 Aug; 23(11):1580-7. PubMed ID: 18618663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic properties in functional connectivity changes and striatal dopamine deficiency in Parkinson's disease.
    Asendorf AL; Theis H; Tittgemeyer M; Timmermann L; Fink GR; Drzezga A; Eggers C; Ruppert-Junck MC; Pedrosa DJ; Hoenig MC; van Eimeren T
    Hum Brain Mapp; 2024 Jul; 45(10):e26776. PubMed ID: 38958131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction.
    Sakakibara R; Shinotoh H; Uchiyama T; Yoshiyama M; Hattori T; Yamanishi T
    J Neurol Sci; 2001 Jun; 187(1-2):55-9. PubMed ID: 11440745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of future weight change with dopamine transporter in patients with Parkinson's disease.
    Pak K; Kim H; Seok JW; Lee MJ; Shin S; Kim K; Lee JM; Seo Y; Kim BS; Jun S; Kim IJ
    J Neural Transm (Vienna); 2019 Jun; 126(6):723-729. PubMed ID: 31102003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
    Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease.
    Muñoz-Delgado L; Labrador-Espinosa MÁ; Macías-García D; Jesús S; Benítez Zamora B; Fernández-Rodríguez P; Adarmes-Gómez AD; Reina Castillo MI; Castro-Labrador S; Silva-Rodríguez J; Carrillo F; García Solís D; Grothe MJ; Mir P
    Mov Disord; 2023 May; 38(5):755-763. PubMed ID: 36912400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olfactory dysfunction and striatal dopamine transporter binding in motor subtypes of Parkinson's disease.
    Nabizadeh F; Sodeifian F; Pirahesh K
    Neurol Sci; 2022 Aug; 43(8):4745-4752. PubMed ID: 35508569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal dopamine and learning strategy-an (123)I-FP-CIT SPECT study.
    Berger HJ; Cools AR; Horstink MW; Oyen WJ; Verhoeven EW; van der Werf SP
    Neuropsychologia; 2004; 42(8):1071-8. PubMed ID: 15093146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease.
    Hinkle JT; Perepezko K; Mills KA; Mari Z; Butala A; Dawson TM; Pantelyat A; Rosenthal LS; Pontone GM
    Parkinsonism Relat Disord; 2018 Oct; 55():8-14. PubMed ID: 30146185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrastriatal
    Nicastro N; Garibotto V; Burkhard PR
    BMC Neurol; 2020 May; 20(1):192. PubMed ID: 32416724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms.
    Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O
    Nucl Med Commun; 2005 May; 26(5):421-6. PubMed ID: 15838424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking in Patients with Parkinson's Disease: preliminary striatal DaT-SPECT findings.
    Gigante AF; Defazio G; Niccoli Asabella A; Superbo M; Ferrari C; Liuzzi D; Iliceto G; Livrea P; Rubini G
    Acta Neurol Scand; 2016 Oct; 134(4):265-70. PubMed ID: 26659996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Striatal presynaptic dopaminergic dysfunction in gambling disorder: A
    Pettorruso M; Martinotti G; Cocciolillo F; De Risio L; Cinquino A; Di Nicola M; Camardese G; Migliara G; Moccia L; Conte E; Janiri L; Di Giuda D
    Addict Biol; 2019 Sep; 24(5):1077-1086. PubMed ID: 30226290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease Patients.
    Rossi C; Genovesi D; Marzullo P; Giorgetti A; Filidei E; Corsini GU; Bonuccelli U; Ceravolo R
    Clin Neuropharmacol; 2017; 40(1):34-36. PubMed ID: 27941527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects.
    Yuan J; Liu XD; Han M; Lv RB; Wang YK; Zhang GM; Li Y
    Addict Biol; 2017 Jan; 22(1):229-234. PubMed ID: 26040446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-related loss of olfactory sensitivity: association to dopamine transporter binding in putamen.
    Larsson M; Farde L; Hummel T; Witt M; Lindroth NE; Bäckman L
    Neuroscience; 2009 Jun; 161(2):422-6. PubMed ID: 19348872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No effect of Parkinson's disease-polygenic load on striatal density of dopaminergic neuron in healthy subjects.
    Pak K; Lee MJ; Kim K; Kim IJ
    Ann Nucl Med; 2021 Nov; 35(11):1187-1192. PubMed ID: 34287783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.